SeraCare Life Sciences, Inc. (Nasdaq:SRLS) announced that it has entered into a loan agreement that provides senior secured credit facilities in the aggregate amount of $20.0 million with Middlesex Savings Bank and Commerce Bank and Trust Company. Subject to the terms of the loan agreement, SeraCare can use these funds for working capital, acquisitions, stock repurchases and other general corporate purposes.

SeraCare Life Sciences, Inc., a life sciences company, provides products and services to facilitate the discovery, development, and production of human and animal diagnostics, and therapeutics.

Winn-Dixie Stores Inc. (Nasdaq:WINN) announced that Laurence Appel, who joined Winn-Dixie in 2002 and formerly served as General Counsel, Corporate Secretary and Senior Vice President of Human Resources, has been named Senior Vice President of Retail Operations. Effective Mr. Appel replaces Frank Eckstein, who has retired from his current role but will continue to serve in an advisory capacity until the end of fiscal year 2011.

Winn-Dixie Stores, Inc. operates as a food retailing company primarily under the Winn-Dixie banner. The company’s stores offer grocery, meat, seafood, produce, deli, bakery, floral, health and beauty, and other general merchandise items.

Keryx Biopharmaceuticals Inc. (Nasdaq:KERX) announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 29th Annual J.P. Morgan Healthcare Conference, being held January 10-13, 2011 at the Westin St. Francis Hotel in San Francisco. Mr. Bentsur's presentation is scheduled to take place on Tuesday, January 11th, at 4:00 p.m. PST (7:00 p.m. EST). A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website.

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.

**********************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.